Gold used as safe driver of cancer drug
22 March, 2012Gold nanoparticles can be used as delivery vehicles for platinum anticancer drugs, improving targeting and uptake into cells, according to research published in this month’s edition of the international journal Inorganic Chemistry.
Study reveals contraceptive cancer risks
07 March, 2012A study has revealed that injectable contraceptives that are widely used around the world influence the risk of developing several types of cancer. The study builds on previous research which found that women using oral contraception have a temporarily increased risk of breast cancer and cervical cancer and a decreased risk of ovarian cancer and cancer of the lining of the womb.
Shark blood holds potential for new antibody technology
05 March, 2012Australian research into shark antibodies that holds out the potential for new drugs and diagnostic agents is a step closer to realising its goal following an agreement with international diagnostic and pharmaceutical giant Roche. The pioneering work, which has attracted worldwide interest, is based on research led by Associate Professor Michael Foley at the La Trobe Institute of Molecular Science (LIMS).
Mitochondrial dysfunction precedes memory loss in Alzheimer’s disease
02 March, 2012 by Brian KilenMitochondria - subunits inside cells that produce energy - have long been thought to play a role in Alzheimer’s disease. Now, Mayo Clinic researchers using genetic mouse models have discovered that mitochondria in the brain are dysfunctional early in the disease.
Allied announces Coridon to develop HPV therapeutic vaccine
29 February, 2012The board of Allied Healthcare Group has announced that its investment company Coridon has embarked on the development of a next-generation therapeutic Human Papillomavirus (HPV) vaccine. The program will be based on preliminary work by Coridon founder Professor Ian Frazer’s team and follows on from Professor Frazer’s work that resulted in two successful cervical cancer preventative vaccines - Gardasil and Cervarix.
Improved UOW anti-cancer formulation patented in Europe
21 February, 2012A novel formulation for the treatment of metastatic colorectal cancer, developed by University of Wollongong researchers, has been granted patent rights by the European Patent Office. The formulation, called Fluorodex, was developed to address key adverse events associated with current treatment regimens that are used to combat metastatic colorectal cancer.
Method for determination of crotamiton
24 January, 2012Thermo Fisher Scientific has developed an efficient quality control method for the determination of the cis and trans isomers that comprise crotamiton, used in the treatment of scabies and skin pruritus. The method is more efficient than the official protocols of the British Pharmacopoeia (BP) and Pharmacopeia of the People’s Republic of China (PPRC).
Research identifies mutations underlying human hereditary hearing loss
16 January, 2012Hereditary hearing loss is the most common sensory disorder in humans. A German research team led by Ingo Kurth from the Institute of Human Genetics at the University Hospital Jena, Germany, used a number of different methods, including Roche’s NimbleGen Custom Sequence Capture 385K array, to identify the gene mutated in the disease locus of the X-chromosome of a Spanish family with hereditary hearing loss.
Educating stem cells reverses Type 1 diabetes
13 January, 2012Type 1 diabetes is caused by the body’s own immune system attacking its pancreatic islet beta cells and requires daily injections of insulin to regulate the patient’s blood glucose levels. A new method described in BioMed Central’s open access journal BMC Medicine uses stem cells from cord blood to re-educate a diabetic’s own T cells and consequently restart pancreatic function reducing the need for insulin.
JW - bold in para 1 - sense? DB Award for Gamma Knife brain treatment
02 November, 2011A major award to research a treatment for a dangerous and silent brain abnormality has been received.
Possible link between bacterium and colon cancer
21 October, 2011Scientists at Dana-Farber Cancer Institute and the Broad Institute have found strikingly high levels of a bacterium in colorectal cancers, a sign that it might contribute to the disease and potentially be a key to diagnosing, preventing and treating it.
Hypertension may be misdiagnosed
20 October, 201170,000 Australians may have undetected high blood pressure because of sphygmomanometer errors, according to new study.
New way to screen for brain cancer discovered
18 October, 2011Researchers have developed a new way to screen for brain cancer stem cell killers.
Researchers reconstruct genome of the 'Black Death'
18 October, 2011An international research team based in Germany has sequenced the entire genome of the 'Black Death'.
Patent improves speed of DNA analysis
18 October, 2011A US researcher has patented a process that reduces the time it takes to perform DNA analysis from hours to minutes.
